Cost-Effectiveness Analysis in the Context of US Commercial Health Insurance Bryan DowdJohn A. Nyman Commentary 08 March 2019 Pages: 743 - 744
Combining the Power of Artificial Intelligence with the Richness of Healthcare Claims Data: Opportunities and Challenges David ThesmarDavid SraerPaul Greenberg Leading Article Open access 08 March 2019 Pages: 745 - 752
Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Joanna PicotNeelam KalitaKeith Cooper Review Article 17 October 2018 Pages: 753 - 762
Pirfenidone for Treating Idiopathic Pulmonary Fibrosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Sarah DavisRachid RafiaMunira Essat Review Article 22 October 2018 Pages: 763 - 775
Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review Dongzhe HongLei SiLizheng Shi Systematic Review 11 March 2019 Pages: 777 - 818
Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial Fuxiao LiXiang LiYang Ke Original Research article 27 February 2019 Pages: 819 - 827
A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis Devin IncertiJeffrey R. CurtisJeroen P. Jansen Original Research Article 09 February 2019 Pages: 829 - 843
Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden Santiago Zuluaga-SanchezMegan TeynorAndrew Lloyd Original Research Article Open access 04 February 2019 Pages: 845 - 865
Correction to: The Impact of Hospital Costing Methods on Cost-Effectiveness Analysis: A Case Study José LealStefania ManettiJames Buchanan Correction Open access 05 March 2019 Pages: 867 - 867
Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal Hema MistryChidozie NdukaJames Mason Correction Open access 19 February 2019 Pages: 869 - 869